The role of oral coenzyme Q10 in patients undergoing coronary artery bypass graft surgery.
Makhija N, Sendasgupta C, Kiran U, Lakshmy R, Hote MP, Choudhary SK, Airan B, Abraham R.
Makhija N, et al. Among authors: kiran u.
J Cardiothorac Vasc Anesth. 2008 Dec;22(6):832-9. doi: 10.1053/j.jvca.2008.03.007. Epub 2008 Jun 6.
J Cardiothorac Vasc Anesth. 2008.
PMID: 18834786
Clinical Trial.
PARTICIPANTS: Thirty patients scheduled for elective CABG surgery. INTERVENTIONS: The study group (n = 15) received oral coenzyme Q10, 150 to 180 mg/d, for 7 to 10 days preoperatively, whereas the control group (n = 15) did not receive any antioxidant or placebo. .. …
PARTICIPANTS: Thirty patients scheduled for elective CABG surgery. INTERVENTIONS: The study group (n = 15) received oral coenzyme Q10 …